Company Name
NeuroFix, S.A.

Activity
Lipid-based therapies for the treatment of neurological pathologies

CIF
A37542834

Sector
Bio

Address
Parque Científico Universidad de Salamanca, M3 PB5 CP37185 Villamayor - Salamanca

EPM Joining Date
23/03/2020

Creation Date
20/03/2015

Investors email contact
info@neurofixpharma.com

Presenting Partner
EpM

Company profile

Neurofix is a biotechnology company founded by experienced scientists and executives. Our pipeline consists of products both at clinical and pre-clinical development stages.

Lipid-based therapies for the treatment of neurological pathologies


On the Road to BME Growth

  • 13/10/2020 - Capital Disclosure
  • 07/04/2021 - Bylaws modification BME Growth requirements
  • 26/10/2020 - Board of Directors
  • 12/05/2020 - Transformation in PLC

Relevant data

(thousand of Euros)2018201920202021
Net worth3717311.074,271.956,08
Net business turnover00000000
Financial debt00252469,05552
Ebitda-5156-178,6-301,31
Net Profit-3842-199,51-15,34
Average number of employees02030303

 

Investment Rounds

Date Status Amount Minimum Ticket
12-04-2021Closed1.500.0001035,00
18-01-2022Closed3.500.000264,00

 

Documentation

Contact Us

You are just one step away from growing your company